ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,898, issued on March 24, was assigned to Orionis Biosciences Inc. (Waltham, Mass.) and Orionis Biosciences BV (Zwijnaarde, Belgium).
"Therapeutic interferon alpha 1 proteins" was invented by Nikolai Kley (Waltham, Mass.), Erik Depla (Zwijnaarde, Belgium), Lennart Zabeau (Zwijnaarde, Belgium) and Jan Tavernier (Zwijnaarde, Belgium).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates, in part, to chimeric proteins or chimeric protein complexes, such as Fc-based chimeric protein complexes, comprising interferon alpha 1, or a variant thereof, and their use as therapeutic agents."
The patent was filed on July 21, 2022, under App...